The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. This application provides novel compositions and methods for treating various disorders or conditions that are associated with a dysfunctional intestinal microbiota. In particular, this application provides compositions and methods that can treat or cure gastrointestinal (GI) disorders such as Inflammatory Bowel Disease (IBD), including, for example, Crohn's Disease and ulcerative colitis.La présente invention concerne le domaine des compositions pharmaceutiques convenant au traitement de maladies chez les mammifères. Ladite invention concerne de nouvelles compositions et méthodes permettant de traiter divers troubles ou états qui sont associés à un microbiote intestinal dysfonctionnel. En particulier, ladite invention concerne des compositions et des méthodes qui peuvent traiter ou guérir des troubles gastro-intestinaux (GI) tels qu'une maladie inflammatoire chronique de l'intestin (MICI), notamment la maladie de Crohn et la colite ulcéreuse.
